{
    "2018-06-23": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novo Says Tresiba Shows Significantly Better Blood Sugar Control",
                "features": {
                    "keywords": [
                        "Tresiba",
                        "blood sugar control",
                        "significantly better"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novo Nordisk: Tresiba Shows Improved Blood Sugar Control Versus Insulin Toujeo",
                "features": {
                    "keywords": [
                        "Tresiba",
                        "improved blood sugar control",
                        "Insulin Toujeo"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novo reveals more Ozempic data on change in body weight by baseline BMI",
                "features": {
                    "keywords": [
                        "Ozempic",
                        "body weight",
                        "baseline BMI"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Drug Pricing Turns to Insulin as Politicians, AMA and Docs Look to Pharma",
                "features": {
                    "keywords": [
                        "drug pricing",
                        "insulin",
                        "politicians",
                        "AMA",
                        "pharma"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}